CoChat

Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review

Open access

The DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Anxiety and related disorders include generalised anxiety disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder and phobic disorders (intense fear of an object or situation). These disorders share the psychological and physical symptoms of anxiety, but each disorder has its own set of characteristic symptoms. Anxiety disorders can be difficult to recognise, particularly in older people (those aged over 65 years). Older people tend to be more reluctant to discuss mental health issues and there is the perception that older people are generally more worried than younger adults. It is estimated that between 3 and 14 out of every 100 older people have an anxiety disorder. Despite treatment, some people will continue to have symptoms of anxiety. People are generally considered to be 'resistant' or 'refractory' to treatment if they have an inadequate response or do not respond to their first treatment. Older adults with an anxiety disorder find it difficult to manage their day-to-day lives and are at an increased risk of comorbid depression, falls, physical and functional disability, and loneliness. OBJECTIVE: To evaluate the effectiveness of pharmacological, psychological and alternative therapies in older adults with an anxiety disorder who have not responded, or have responded inadequately, to treatment. DATA SOURCES: Electronic databases (MEDLINE, MEDLINE In-Process and Other Non-Indexed citations, EMBASE, The Cochrane Library databases, PsycINFO and Web of Science) were searched from inception to September 2013. Bibliographies of relevant systematic reviews were hand-searched to identify additional potentially relevant studies. ClinicalTrials.gov was searched for ongoing and planned studies. REVIEW METHODS: A systematic review of the clinical effectiveness of treatments for treatment-resistant anxiety in older adults was carried out. RESULTS: No randomised controlled trial or prospective comparative observational study was identified meeting the prespecified inclusion criteria. Therefore, it was not possible to draw any conclusions on clinical effectiveness. LIMITATIONS: As no study was identified in older adults, there is uncertainty as to which treatments are clinically effective for older adults with an anxiety disorder who have not responded to prior treatment. The comprehensive methods implemented to carry out this review are a key strength of the research presented. However, this review highlights the extreme lack of research in this area, identifying no comparative studies, which is a marked limitation. CONCLUSIONS: Specific studies evaluating interventions in older adults with an anxiety disorder who have not responded to first-line treatment are needed to address the lack of evidence. The lack of evidence in this area means that older adults are perhaps receiving inappropriate treatment or are not receiving a particular treatment because there is limited evidence to support its use. At this time there is scope to develop guidance on service provision and, as a consequence, to advance the standard of care received by older adults with a treatment-resistant anxiety disorder in primary and secondary care. Evaluation of the relative clinical effectiveness and acceptability of pharmacological and psychological treatment in older adults with an anxiety disorder that has not responded to first-line treatment is key future research to inform decision-making of clinicians and patients. An important consideration would be the enrolment of older adults who would be representative of older adults in general, i.e. those with multiple comorbid physical and mental disorders who might require polypharmacy. STUDY REGISTRATION: The protocol for the systematic review is registered on PROSPERO (registration number CRD42013005612). FUNDING: The National Institute for Health Research Health Technology Assessment programme.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3310/hta18500

Cites

174 of 174 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 174 references

Research works printed but not linked: 20

  1. American Psychiatric Association, 2013, Highlights of Changes from DSM-IV-TR to DSM-5
  2. Gellis, 2007, Anxiety Disorders among Older Adults (literature review)
  3. National Collaborating Centre for Mental Health, 2011, Generalised Anxiety Disorder in Adults. The NICE Guideline on Management In Primary, Secondary and Community Care
  4. National Collaborating Centre for Mental Health, 2005, Post-Traumatic Stress Disorder. The Management of PTSD in Adults and Children in Primary and Secondary Care
  5. National Collaborating Centre for Mental Health, 2005, Obsessive–Compulsive Disorder: Core Interventions in the Treatment of Obsessive–Compulsive Disorder and Body Dysmorphic Disorder
  6. National Collaborating Centre for Mental Health, 2013, Social Anxiety Disorder: Recognition, Assessment and Treatment
  7. National Institute for Health and Care Excellence, 2013, Pathway for Generalised Anxiety Disorder
  8. National Institute for Health and Care Excellence, 2013, Pathway for Panic Disorder
  9. National Institute for Health and Care Excellence, 2013, Pathway for Obsessive–Compulsive Disorder and Body Dysmorphic Disorder
  10. National Institute for Health and Care Excellence, 2013, Pathway for Post-Traumatic Stress Disorder
  11. National Institute for Health and Care Excellence, 2013, Pathway for Social Anxiety Disorder
  12. Gale C, Millichamp J. Generalised Anxiety Disorder. Clinical Evidence, 2011. URL: http://clinicalevidence.bmj.com/x/systematic-review/1002/interventions.html (accessed December 2013).
  13. Kumar S, Malone D. Panic Disorder. Clinical Evidence, 2008. URL: http://clinicalevidence.bmj.com/x/systematic-review/1010/interventions.html (accessed December 2013).
  14. Bisson JI. Post-Traumatic Stress Disorder. Clinical Evidence, 2009. URL: http://clinicalevidence.bmj.com/x/systematic-review/1005/interventions.html (accessed December 2013).
  15. Soomro GM. Obsessive Compulsive Disorder. Clinical Evidence, 2011. URL: http://clinicalevidence.bmj.com/x/systematic-review/1004/interventions.html (accessed December 2013).
  16. Centre for Reviews and Dissemination, 2013, Clinical Effectiveness of Interventions for Treatment-Resistant Anxiety in Older People: a Systematic Review (PROSPERO record)
  17. Scottish Intercollegiate Guidelines Network, 2013, Search Filters
  18. Clinical Evidence. Study Design Search Filters. 2013. URL: http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665076.html (accessed December 2013).
  19. Ginsberg, 2005, Ziprasidone for treatment-resistant generalized anxiety disorder, Prim Psychiatry, 12, 28
  20. Prasko, 2007, The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study, Neuro Endocrinol Lett, 28, 33

Cited by

Metadata

Authors
Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J.
Affiliations
  • BMJ Group (United Kingdom) (GB)
  • University of Southampton (GB)
Corresponding author
Barton, Samantha
Venue
Health Technology Assessment
Published
2014-08
Volume
18
Issue
50
Pages
1-60
ISSN
  • 1366-5278 (ISSN-L)
  • 2046-4924
OpenAlex
W2081899968
Cited by
36
References
175
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 4
FWCI
0.32
Type
journal article
Language
en
Open access
Locations
  • Health Technology Assessment (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute for Health Research (13/39/01)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
treatment-resistant anxiety, older adults, anxiety disorders, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, phobia, pharmacotherapy, psychological intervention, complementary and alternative medicine, comorbid depression, falls, functional disability, loneliness, absence of evidence, research gaps, treatment non-response
MeSH terms
Age Factors, Aged, Anxiety, Humans, Psychotherapy, Anti-Anxiety Agents, Treatment Outcome, Treatment Failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.